Drug manufacturer Sanofi has sent letters to 340B covered entities that have complained to federal authorities about its denials of 340B pricing on drugs shipped to contract pharmacies, covered entity representatives say.
Sanofi has acknowledged but not responded to requests
…
The dumping of a controversial Trump administration rule limiting what 340B health centers can charge patients for insulin and EpiPen-type devices took a big step closer to being finalized last week.
Late last week Thursday, the U.S. Health Resources
…SPONSORED CONTENT
An HIV diagnosis does not have the same meaning today as when the virus first emerged in the 1980s. People living with HIV can now expect to live a long, full life, as long as they adhere to a prescribed antiretroviral treatment regimen. AIDS Healthcare Foundation (AHF), the largest provider of HIV/AIDS medical care globally, plays a key role in ensuring that people living with HIV can adhere to treatment and stay healthy.
In HIV care, adherence is everything. Staying on one’s HIV medications lowers the amount of HIV present in the blood. That means the person living with HIV is healthy and can live a full, normal life. If the level of virus becomes low enough to be undetectable – which it can if the person takes their medications religiously, without fail — the virus can’t be transmitted. That, in turn, breaks the chain
…
An Arkansas Insurance Department hearing officer said last week she would decide by Oct. 13 whether to stay enforcement of a state law requiring drug manufacturers to honor 340B contract pharmacy arrangements pending resolution of a bevy of federal lawsuits
…
Nine friend-of-the-court briefs have been filed in the nation’s highest court urging rejection of an appeals court’s decision last year that upheld a huge cut in 340B hospitals’ Medicare reimbursement for physician administered drugs.
Thirty-seven state and regional hospital associations
…
Napo Pharmaceuticals yesterday posted a public notice to 340B covered entities about how to obtain 340B pricing on Mytesi, an antidiarrheal for patients living with HIV/AIDS who take antiretroviral drugs.
Napo said in the notice on the U.S. Health
…
Q: Where did you grow up?
I grew up in Alpharetta, GA, near Atlanta and have spent the last 17 years in Charlotte, NC.
Q: Where did
…
340B covered entities are breathing easier today upon learning that U.S. House Democrats excluded much-feared Medicaid managed care “spread pricing” language from forthcoming drug pricing legislation.
The House Energy & Commerce Committee late yesterday released the text of the 16
…
U.S. Health and Human Services Secretary Xavier Becerra yesterday reiterated HHS’ “strong support for the 340B Drug Pricing Program” in a 29-page plan to lower drug prices.
Becerra’s Sept. 9 report to White House domestic and economic policy counselors
…
North Carolina lawmakers approved a final deal Wednesday to protect some, but not all, of the state’s 340B covered entities against discrimination by pharmacy benefit managers (PBMs).
Under an agreement a House-Senate conference committee reached on Sept. 8, 340B
…*Sign up for news summaries and alerts from 340B Report
